Vaccines and cardiovascular outcomes: lessons learned from influenza epidemics

被引：5

作者：

Yedlapati, Siva H. ^{[1
]}

Mendu, Anuradha ^{[1
]}

Tummala, Venkat R. ^{[2
]}

Maganti, Sowmith S. ^{[2
]}

Nasir, Khurram ^{[3
]}

Khan, Safi U. ^{[3
]}

机构：

[1] Erie Cty Med Ctr & Labs, Dept Med, 462 Grider St, Buffalo, NY 14215 USA

[2] Virginia Commonwealth Univ, Dept Biol, 1000 Cary St, Richmond, VA 23284 USA

[3] DeBakey Heart & Vasc Ctr, Dept Cardiol, 6565 Fannin St, Houston, TX 77030 USA

来源：

EUROPEAN HEART JOURNAL SUPPLEMENTS | 2023年 / 25卷

关键词：

Cardiovascular disease; Influenza vaccine; Prevention; ACUTE CORONARY SYNDROMES; CORONAVIRUS DISEASE 2019; MYOCARDIAL-INFARCTION; HEART-FAILURE; SECONDARY PREVENTION; FLU VACCINATION; ARTERY-DISEASE; SEASONAL INFLUENZA; ELDERLY-PATIENTS; RISK;

D O I：

10.1093/eurheartjsupp/suac110

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Cardiovascular disease (CVD) is the leading cause of death in the world and is largely preventable. An increasing amount of evidence suggests that annual influenza vaccination reduces CVD-related morbidity and mortality. Despite various clinical guidelines recommending annual influenza vaccination for the general population for influenza-like illness risk reduction, with a particular emphasis on people with CVD, vaccination rates fall consistently below the goal established by the World Health Organization. This review outlines the importance of influenza vaccination, mechanisms of cardiovascular events in influenza, summarizing the available literature on the effects of influenza vaccine in CVD and the benefits of influenza vaccine during the COVID-19 pandemic.

引用

页码：A17 / A24

页数：8